Novel folate-targeted docetaxel-loaded nanoparticles for tumour targeting: in vitro and in vivo evaluation
| Autor: | Hai-Xue Kuang, Yifei Guo, Xiu-Qing Wang, Dongdong Bi, Meihua Han, Zhitao Li |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Chemistry
Stereochemistry General Chemical Engineering technology industry and agriculture Nanoparticle 02 engineering and technology General Chemistry 010402 general chemistry 021001 nanoscience & nanotechnology 01 natural sciences In vitro 0104 chemical sciences Docetaxel In vivo Drug delivery Cancer cell polycyclic compounds Zeta potential medicine Biophysics Distribution (pharmacology) lipids (amino acids peptides and proteins) 0210 nano-technology medicine.drug |
| Zdroj: | RSC Advances. 6:64306-64314 |
| ISSN: | 2046-2069 |
| Popis: | Cholesterol-PEG1000 (Chol-PEG) has shown great potential in drug delivery. In our work, the synthesis of Chol-PEG1000-FA (folic acid) was firstly achieved via an amide reaction of NH2 on the surface of Chol-PEG1000-NH2, and then docetaxel-loaded Chol-PEG1000-FA nanoparticles were prepared by the precipitation–ultrasonication combined high-pressure homogenization (HPH) technique, and were characterized by particle size, zeta potential and morphology; meanwhile the average drug loading of the resulting DTX/Chol-PEG1000-FA nanoparticles reached up to 68%. The anti-tumor efficiency and targeting ability of docetaxel-loaded Chol-PEG1000-FA nanoparticles (DTX-FA-Nps) were demonstrated by their in vitro and in vivo anti-tumor activity against 4T1 cells. The docetaxel-loaded Chol-PEG1000 nanoparticles with and without FA conjugation proved to be of satisfactory size and distribution, with favorable drug release and high drug encapsulation efficiency. In vitro results showed the higher anti-tumor efficiency of the DTX-FA-Nps and DTX-Nps (docetaxel-loaded Chol-PEG1000 nanoparticles) than docetaxel solutions (DTX-Sol). The tumor-targeting effects of the FA conjugated Chol-PEG1000 are also studied. The IC50 values of DTX-Sol, DTX-Nps and DTX-FA-Nps are 1.6260, 0.3772 and 0.0171 μg mL−1, respectively, for 4T1 cancer cells after 48 h of treatment. The inhibition rate for the DTX-FA-Nps at 10 mg kg−1 was 74.83% (P < 0.01). Based on these results, the DTX-loaded Chol-PEG1000-FA nanoparticles may be a promising targeted delivery system for breast cancer therapy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|